Literature DB >> 14988504

Molecular mechanism of enantioselective proton transfer to carbon in catalytic antibody 14D9.

Lei Zheng1, Ulrich Baumann, Jean-Louis Reymond.   

Abstract

Catalytic antibody 14D9 catalyzes the enantioselective protonation of prochiral enol ethers with high enantioselectivity (>99% ee) and a practical turnover (k(cat) = 0.4 s(-1)), allowing for preparative scale applications. This antibody represents one of the rare examples of catalytic antibodies promoting acid-catalyzed processes. Antibody 14D9 was cloned and expressed as a chimeric Fab fragment in Escherichia coli. Crystal structures of Fab 14D9 as apo form and of its close analog 19C9 in complex with the transition state analog were determined at 2.8-A resolution. A series of site-directed mutagenesis experiments was carried out to probe the role of individual active-site amino acids. Proton transfer to carbon is catalyzed by a hydrogen bond network formed by the side chains of Asp(H101) and Tyr(L36) with a water molecule serving as a relay. The intermediate oxocarbonium ion formed during the protonation step is trapped by the same water molecule, resulting in an overall syn-addition of water to the enol ether's double bond. The enantioselectivity is caused by steric crowding at the active site, mainly because of the side chain of Phe(H84). The 20-fold lower activity of 19C9 compared with 14D9 was traced down to residue Thr(L46), which forms a nonproductive hydrogen bond with the catalytic residue Asp(H101), which competes with the critical Asp(H101)-Tyr(L36) hydrogen bond and therefore reduces catalytic efficiency. The catalytic activity of 19C9 was restored to that of 14D9 by using either site-directed mutagenesis (Thr(L46)Ala) or chain shuffling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988504      PMCID: PMC376184          DOI: 10.1073/pnas.0400263101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  Catalytic antibodies and other biomimetic catalysts.

Authors:  J D Stevenson; N R Thomas
Journal:  Nat Prod Rep       Date:  2000-12       Impact factor: 13.423

2.  A comparative analysis of the immunological evolution of antibody 28B4.

Authors:  J Yin; E C Mundorff; P L Yang; K U Wendt; D Hanway; R C Stevens; P G Schultz
Journal:  Biochemistry       Date:  2001-09-11       Impact factor: 3.162

3.  Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement.

Authors:  E C Mundorff; M A Hanson; A Varvak; H Ulrich; P G Schultz; R C Stevens
Journal:  Biochemistry       Date:  2000-02-01       Impact factor: 3.162

4.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

5.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

6.  Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.

Authors:  A S Kang; T M Jones; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.

Authors:  C F Barbas; A S Kang; R A Lerner; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Large rate accelerations in antibody catalysis by strategic use of haptenic charge.

Authors:  S N Thorn; R G Daniels; M T Auditor; D Hilvert
Journal:  Nature       Date:  1995-01-19       Impact factor: 49.962

9.  Structure of the triosephosphate isomerase-phosphoglycolohydroxamate complex: an analogue of the intermediate on the reaction pathway.

Authors:  R C Davenport; P A Bash; B A Seaton; M Karplus; G A Petsko; D Ringe
Journal:  Biochemistry       Date:  1991-06-18       Impact factor: 3.162

10.  Expanding the 43C9 class of catalytic antibodies using a chain-shuffling approach.

Authors:  G P Miller; B A Posner; S J Benkovic
Journal:  Bioorg Med Chem       Date:  1997-03       Impact factor: 3.641

View more
  2 in total

1.  An efficient one-step site-directed and site-saturation mutagenesis protocol.

Authors:  Lei Zheng; Ulrich Baumann; Jean-Louis Reymond
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

2.  Conformational adaptability determining antibody recognition to distomer: structure analysis of enantioselective antibody against chiral drug gatifloxacin.

Authors:  Lanteng Wang; Wei Xie; Wenyang Jiao; Chijian Zhang; Xiangmei Li; Zhenlin Xu; Xin-An Huang; Hongtao Lei; Xing Shen
Journal:  RSC Adv       Date:  2021-12-13       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.